{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:20:33Z","timestamp":1765484433780,"version":"3.37.3"},"reference-count":74,"publisher":"Endocrinology Research Centre","issue":"4","license":[{"start":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T00:00:00Z","timestamp":1726358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.probl-endojournals.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":["www.probl-endojournals.ru"],"crossmark-restriction":true},"short-container-title":["Probl Endokrinol (Mosk)"],"abstract":"<jats:p>Diabetic neuropathy is one of the most common diabetes mellitus complications associated with mediocalcinosis of the lower extremities, a significant decrease in feet bone mineral density, and a high incidence of cardiovascular disease. In most cases, calcium-phosphorus metabolism changes occur in patients with diabetic neuroarthropathy, or Charcot foot, when we can observe feet local osteoporosis, which in 90% of cases associated with a vessel\u2019s calcification of the lower extremities in the majority of diabetes population. A large number of studies presented literature have demonstrated that patients with Charcot foot can have accelerated bone metabolism and increased bone resorption. Patients with Charcot foot often have crucial abnormalities in the calcium-phosphorus parameters, bone metabolism, and levels of vitamin D and its metabolites. In addition, the duration of diabetes mellitus, the degree of its compensation widely affects the development of its micro- and macrovascular complications, which could also accelerate the development of mineral and bone disorders in these types of patients. Multifactorial pathogenesis of these disorders complicates the management of patients with a long and complicated course of diabetes mellitus. This review discusses the peculiarities of vitamin D metabolism, the importance of timely diagnosis in phosphorus-calcium disorders, and the specifics of therapy in these patients. Special attention is paid to the timely diagnosis of the Charcot\u2019s foots acute stage based on the bone marrow edema by MRI evaluation and the possibility of reducing the immobilization period.<\/jats:p>","DOI":"10.14341\/probl13362","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T16:42:57Z","timestamp":1726591377000},"page":"57-64","update-policy":"https:\/\/doi.org\/10.14341\/crossmarkpolicy2018","source":"Crossref","is-referenced-by-count":3,"title":["Etiopathogenetic features of bone metabolism in patients with diabetes mellitus and Charcot foot"],"prefix":"10.14341","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3797-9788","authenticated-orcid":true,"given":"M. V.","family":"Yaroslavceva","sequence":"first","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2654-9451","authenticated-orcid":true,"given":"O. N.","family":"Bondarenko","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4218-4456","authenticated-orcid":true,"given":"Ya. A.","family":"El-Taravi","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8860-8509","authenticated-orcid":true,"given":"S. T.","family":"Magerramova","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6539-466X","authenticated-orcid":true,"given":"E. A.","family":"Pigarova","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. N.","family":"Ulyanova","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6581-4521","authenticated-orcid":true,"given":"G. R.","family":"Galstyan","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5458","published-online":{"date-parts":[[2024,9,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Jansen RB, Svendsen OL. A review of bone metabolism and developments in medical treatment of the diabetic Charcot foot. J Diabetes Complications. \u0438\u044e\u043b\u044c 2018 \u0433.;32(7):708\u201312.","DOI":"10.1016\/j.jdiacomp.2018.04.010"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Lehto S, Niskanen L, Suhonen M, R\u00f6nnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. \u0430\u0432\u0433\u0443\u0441\u0442 1996 \u0433.;16(8):978\u201383.","DOI":"10.1161\/01.ATV.16.8.978"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Jeffcoate W. Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link? Diabetologia. \u0441\u0435\u043d\u0442\u044f\u0431\u0440\u044c 2004 \u0433.;47(9):1488\u201392.","DOI":"10.1007\/s00125-004-1477-5"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Frykberg RG, Belczyk R. Epidemiology of the Charcot foot. Clin Podiatr Med Surg. \u044f\u043d\u0432\u0430\u0440\u044c 2008 \u0433.;25(1):17\u201328, v.","DOI":"10.1016\/j.cpm.2007.10.001"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Jeffcoate W, Lima J, Nobrega L. The Charcot foot. Diabet Med. \u0430\u043f\u0440\u0435\u043b\u044c 2000 \u0433.;17(4):253\u20138","DOI":"10.1046\/j.1464-5491.2000.00233.x"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Doherty TM, Fitzpatrick LA, Inoue D, Qiao JH, Fishbein MC, Detrano RC, \u0438 \u0434\u0440. Molecular, endocrine, and genetic mechanisms of arterial calcification. Endocr Rev. \u0430\u0432\u0433\u0443\u0441\u0442 2004 \u0433.;25(4):629\u201372.","DOI":"10.1210\/er.2003-0015"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Yammine K, Hayek F, Assi C. Is there an association between vitamin D and diabetic foot disease? A meta-analysis. Wound Repair Regen. \u044f\u043d\u0432\u0430\u0440\u044c 2020 \u0433.;28(1):90\u20136.","DOI":"10.1111\/wrr.12762"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Greenhagen RM, Frykberg RG, Wukich DK. Serum vitamin D and diabetic foot complications. Diabet Foot Ankle. 19 \u0444\u0435\u0432\u0440\u0430\u043b\u044c 2019 \u0433.;10(1):1579631.","DOI":"10.1080\/2000625X.2019.1579631"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis. \u0441\u0435\u043d\u0442\u044f\u0431\u0440\u044c 2011 \u0433.;58(3):374\u201382.","DOI":"10.1053\/j.ajkd.2011.03.020"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Jayedi A, Soltani S, Shab-Bidar S. Vitamin D status and all-cause mortality in patients with chronic kidney disease: A systematic review and dose-response meta-analysis. J Clin Endocrinol Metab. \u0438\u044e\u043b\u044c 2017 \u0433.;102(7):2136\u201345.","DOI":"10.1210\/jc.2017-00105"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Starup-Linde J, Gregersen S, Vestergaard P. Associations with fracture in patients with diabetes: a nested case-control study. BMJ Open. 12 \u0444\u0435\u0432\u0440\u0430\u043b\u044c 2016 \u0433.;6(2):e009686.","DOI":"10.1136\/bmjopen-2015-009686"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int. \u0430\u043f\u0440\u0435\u043b\u044c 2007 \u0433.;18(4):427\u201344.","DOI":"10.1007\/s00198-006-0253-4"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Rabe OC, Winther-Jensen M, Allin KH, Svendsen OL. Fractures and Osteoporosis in Patients With Diabetes With Charcot Foot. Diabetes Care. \u0441\u0435\u043d\u0442\u044f\u0431\u0440\u044c 2021 \u0433.;44(9):2033\u20138.","DOI":"10.2337\/dc21-0369"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Petrova NL, Edmonds ME. A prospective study of calcaneal bone mineral density in acute Charcot osteoarthropathy. Diabetes Care. \u043e\u043a\u0442\u044f\u0431\u0440\u044c 2010 \u0433.;33(10):2254\u20136.","DOI":"10.2337\/dc10-0636"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Jansen RB, Christensen TM, B\u00fclow J, R\u00f8rdam L, Holstein PE, J\u00f8rgensen NR, \u0438 \u0434\u0440. Bone mineral density and markers of bone turnover and inflammation in diabetes patients with or without a Charcot foot: An 8.5-year prospective case-control study. J Diabetes Complications. \u0444\u0435\u0432\u0440\u0430\u043b\u044c 2018 \u0433.;32(2):164\u201370.","DOI":"10.1016\/j.jdiacomp.2017.11.004"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Kemink SA, Hermus AR, Swinkels LM, Lutterman JA, Smals AG. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J Endocrinol Invest. \u043c\u0430\u0439 2000 \u0433.;23(5):295\u2013303.","DOI":"10.1007\/BF03343726"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Liao CC, Lin CS, Shih CC, Yeh CC, Chang YC, Lee YW, \u0438 \u0434\u0440. Increased risk of fracture and postfracture adverse events in patients with diabetes: two nationwide population-based retrospective cohort studies. Diabetes Care. \u0430\u0432\u0433\u0443\u0441\u0442 2014 \u0433.;37(8):2246\u201352.","DOI":"10.2337\/dc13-2957"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Meier C, Schwartz AV, Egger A, Lecka-Czernik B. Effects of diabetes drugs on the skeleton. Bone. \u044f\u043d\u0432\u0430\u0440\u044c 2016 \u0433.;82:93\u2013100.","DOI":"10.1016\/j.bone.2015.04.026"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Yamada C, Yamada Y, Tsukiyama K, Yamada K, Udagawa N, Takahashi N, \u0438 \u0434\u0440. The murine glucagon-like peptide-1 receptor is essential for control of bone resorption. Endocrinology. \u0444\u0435\u0432\u0440\u0430\u043b\u044c 2008 \u0433.;149(2):574\u20139.","DOI":"10.1210\/en.2007-1292"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Henriksen DB, Alexandersen P, Bjarnason NH, Vilsb\u00f8ll T, Hartmann B, Henriksen EEG, \u0438 \u0434\u0440. Role of gastrointestinal hormones in postprandial reduction of bone resorption. J Bone Miner Res. \u0434\u0435\u043a\u0430\u0431\u0440\u044c 2003 \u0433.;18(12):2180\u20139.","DOI":"10.1359\/jbmr.2003.18.12.2180"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Zhang YS, Zheng YD, Yuan Y, Chen SC, Xie BC. Effects of Anti-Diabetic Drugs on Fracture Risk: A Systematic Review and Network Meta-Analysis. Front Endocrinol (Lausanne). 14 \u043e\u043a\u0442\u044f\u0431\u0440\u044c 2021 \u0433.;12:735824.","DOI":"10.3389\/fendo.2021.735824"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Lou Y, Yu Y, Duan J, Bi S, Swe KNC, Xi Z, \u0438 \u0434\u0440. Sodium-glucose cotransporter 2 inhibitors and fracture risk in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Ther Adv Chronic Dis. 26 \u0441\u0435\u043d\u0442\u044f\u0431\u0440\u044c 2020 \u0433.;11:2040622320961599.","DOI":"10.1177\/2040622320961599"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Schoppet M, Al-Fakhri N, Franke FE, Katz N, Barth PJ, Maisch B, \u0438 \u0434\u0440. Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in M\u00f6nckeberg\u2019s sclerosis and atherosclerosis. J Clin Endocrinol Metab. \u0430\u0432\u0433\u0443\u0441\u0442 2004 \u0433.;89(8):4104\u201312.","DOI":"10.1210\/jc.2003-031432"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Petrova NL, Petrov PK, Edmonds ME, Shanahan CM. Novel use of a Dektak 150 surface profiler unmasks differences in resorption pit profiles between control and Charcot patient osteoclasts. Calcif Tissue Int. \u0430\u043f\u0440\u0435\u043b\u044c 2014 \u0433.;94(4):403\u201311.","DOI":"10.1007\/s00223-013-9820-9"},{"key":"ref25","unstructured":"\u042f\u0440\u043e\u0441\u043b\u0430\u0432\u0446\u0435\u0432\u0430 \u041c.\u0412., \u0423\u043b\u044c\u044f\u043d\u043e\u0432\u0430 \u0418.\u041d., \u0413\u0430\u043b\u0441\u0442\u044f\u043d \u0413.\u0420.,  \u0418\u043b\u044c\u0438\u043d \u0410.\u0412., \u041d\u0438\u043a\u0430\u043d\u043a\u0438\u043d\u0430 \u041b.\u0412., \u0420\u0435\u043c\u0438\u0437\u043e\u0432 \u041e.\u0412. C\u043e\u0441\u0442\u043e\u044f\u043d\u0438\u0435 \u0441\u0438\u0441\u0442\u0435\u043c\u044b \u043e\u0441\u0442\u0435\u043e\u043f\u0440\u043e\u0442\u0435\u0433\u0435\u0440\u0438\u043d (OPG) \u043b\u0438\u0433\u0430\u043d\u0434 \u0440\u0435\u0446\u0435\u043f\u0442\u043e\u0440\u0430-\u0430\u043a\u0442\u0438\u0432\u0430\u0442\u043e\u0440\u0430 \u044f\u0434\u0435\u0440\u043d\u043e\u0433\u043e \u0444\u0430\u043a\u0442\u043e\u0440\u0430 \u043a\u0430\u043f\u043f\u0430-\u0412 (RANKL) \u0443 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432 \u0441 \u0434\u0438\u0430\u0431\u0435\u0442\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u043e\u0441\u0442\u0435\u043e\u0430\u0440\u0442\u0440\u043e\u043f\u0430\u0442\u0438\u0435\u0439 \u0438 \u043c\u0435\u0434\u0438\u0430\u043a\u0430\u043b\u044c\u0446\u0438\u043d\u043e\u0437\u043e\u043c \u0430\u0440\u0442\u0435\u0440\u0438\u0439 \u043d\u0438\u0436\u043d\u0438\u0445 \u043a\u043e\u043d\u0435\u0447\u043d\u043e\u0441\u0442\u0435\u0439. \u041e\u0441\u0442\u0435\u043e\u043f\u043e\u0440\u043e\u0437 \u0438 \u043e\u0441\u0442\u0435\u043e\u043f\u0430\u0442\u0438\u0438. 2008 \u0433.;(1):9\u201313."},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Patel DD, Vachhani U, Rajput A, Raghavani P, Parchwani DN, Dholariya S. Analysis of the Prevalence and Severity of Dysregulated Bone Mineral Homeostasis in Nondialyzed Chronic Kidney Disease Patients. J Lab Physicians. \u0438\u044e\u043d\u044c 2022 \u0433.;14(2):144\u201350.","DOI":"10.1055\/s-0041-1732495"},{"key":"ref27","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. \u0430\u0432\u0433\u0443\u0441\u0442 2009 \u0433.;(113):S1-130."},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"KDOQI, National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis. \u043c\u0430\u0439 2006 \u0433.;47(5 Suppl 3):S11-145.","DOI":"10.1053\/j.ajkd.2006.03.011"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, \u0438 \u0434\u0440. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. \u0441\u0435\u043d\u0442\u044f\u0431\u0440\u044c 2008 \u0433.;52(3):519\u201330.","DOI":"10.1053\/j.ajkd.2008.03.020"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Cailleaux PE, Ostertag A, Metzger M, Stengel B, Boucquemont J, Houillier P, \u0438 \u0434\u0440. Longitudinal Bone Loss Occurs at the Radius in CKD. Kidney Int Rep. \u0438\u044e\u043d\u044c 2021 \u0433.;6(6):1525\u201336.","DOI":"10.1016\/j.ekir.2021.03.874"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Nickolas TL, McMahon DJ, Shane E. Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol. \u043d\u043e\u044f\u0431\u0440\u044c 2006 \u0433.;17(11):3223\u201332.","DOI":"10.1681\/ASN.2005111194"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Ure\u00f1a P, Bernard-Poenaru O, Ostertag A, Baudoin C, Cohen-Solal M, Cantor T, \u0438 \u0434\u0440. Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant. \u043d\u043e\u044f\u0431\u0440\u044c 2003 \u0433.;18(11):2325\u201331.","DOI":"10.1093\/ndt\/gfg403"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Moe SM, Nickolas TL. Fractures in Patients with CKD: Time for Action. Clin J Am Soc Nephrol. 7 \u043d\u043e\u044f\u0431\u0440\u044c 2016 \u0433.;11(11):1929\u201331.","DOI":"10.2215\/CJN.09500916"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Iseri K, Carrero JJ, Evans M, Fell\u00e4nder-Tsai L, Berg HE, Runesson B, \u0438 \u0434\u0440. Incidence of Fractures Before and After Dialysis Initiation. J Bone Miner Res. \u0434\u0435\u043a\u0430\u0431\u0440\u044c 2020 \u0433.;35(12):2372\u201380.","DOI":"10.1002\/jbmr.4141"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Naylor KL, Garg AX, Zou G, Langsetmo L, Leslie WD, Fraser LA, \u0438 \u0434\u0440. Comparison of fracture risk prediction among individuals with reduced and normal kidney function. Clin J Am Soc Nephrol. 7 \u0430\u043f\u0440\u0435\u043b\u044c 2015 \u0433.;10(4):646\u201353.","DOI":"10.2215\/CJN.06040614"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Nitsch D, Mylne A, Roderick PJ, Smeeth L, Hubbard R, Fletcher A. Chronic kidney disease and hip fracture-related mortality in older people in the UK. Nephrol Dial Transplant. \u043c\u0430\u0439 2009 \u0433.;24(5):1539\u201344.","DOI":"10.1093\/ndt\/gfn678"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Ure\u00f1a Torres PA, Souberbielle JC, Solal MC. Bone Fragility in Chronic Kidney Disease Stage 3 to 5: The Use of Vitamin D Supplementation. Metabolites. 20 \u043c\u0430\u0440\u0442 2022 \u0433.;12(3):266.","DOI":"10.3390\/metabo12030266"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, \u0438 \u0434\u0440. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what\u2019s changed and why it matters. Kidney Int. \u0438\u044e\u043b\u044c 2017 \u0433.;92(1):26\u201336.","DOI":"10.1016\/j.kint.2017.04.006"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Ferrari SL, Abrahamsen B, Napoli N, Akesson K, Chandran M, Eastell R, \u0438 \u0434\u0440. Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int. \u0434\u0435\u043a\u0430\u0431\u0440\u044c 2018 \u0433.;29(12):2585\u201396.","DOI":"10.1007\/s00198-018-4650-2"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Zheng JS, Luan J, Sofianopoulou E, Sharp SJ, Day FR, Imamura F, \u0438 \u0434\u0440. The association between circulating 25-hydroxyvitamin D metabolites and type 2 diabetes in European populations: A meta-analysis and Mendelian randomisation analysis. PLoS Med. 16 \u043e\u043a\u0442\u044f\u0431\u0440\u044c 2020 \u0433.;17(10):e1003394.","DOI":"10.1371\/journal.pmed.1003394"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Luo BA, Gao F, Qin LL. The Association between Vitamin D Deficiency and Diabetic Retinopathy in Type 2 Diabetes: A Meta-Analysis of Observational Studies. Nutrients. 20 \u043c\u0430\u0440\u0442 2017 \u0433.;9(3):307.","DOI":"10.3390\/nu9030307"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Butler AE, Dargham SR, Latif A, Mokhtar HR, Robay A, Chidiac OM, \u0438 \u0434\u0440. Association of vitamin D3 and its metabolites in patients with and without type 2 diabetes and their relationship to diabetes complications. Ther Adv Chronic Dis. 2020 \u0433.;11:2040622320924159.","DOI":"10.1177\/2040622320924159"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Yun HJ, Ryoo SR, Kim JE, Choi YJ, Park I, Shin GT, \u0438 \u0434\u0440. Trabecular bone score may indicate chronic kidney disease-mineral and bone disorder (CKD-MBD) phenotypes in hemodialysis patients: a prospective observational study. BMC Nephrol. 25 \u0438\u044e\u043b\u044c 2020 \u0433.;21(1):299.","DOI":"10.1186\/s12882-020-01944-0"},{"key":"ref44","unstructured":"D\u00edaz L\u00f3pez JB, Jorgetti V, Caorsi H, Ferreira A, Palma A, Menendez P, \u0438 \u0434\u0440. Epidemiology of renal osteodystrophy in Iberoamerica. Nephrol Dial Transplant. 1998 \u0433.;13 Suppl 3:41\u20135."},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Ara\u00fajo SMHA, Ambrosoni P, Lob\u00e3o RRS, Caorsi H, Moys\u00e9s RMA, Barreto FC, \u0438 \u0434\u0440. The renal osteodystrophy pattern in Brazil and Uruguay: an overview. Kidney Int Suppl. \u0438\u044e\u043d\u044c 2003 \u0433.;(85):S54-56.","DOI":"10.1046\/j.1523-1755.63.s85.13.x"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Oliveira RB de, Silva EN da, Charpinel DMF, Gueiros JEB, Neves CL, Sampaio E de A, \u0438 \u0434\u0440. Secondary hyperparathyroidism status in Brazil: Brazilian census of parathyroidectomy. J Bras Nefrol. \u0434\u0435\u043a\u0430\u0431\u0440\u044c 2011 \u0433.;33(4):457\u201362.","DOI":"10.1590\/S0101-28002011000400011"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Naves-D\u00edaz M, Passlick-Deetjen J, Guinsburg A, Marelli C, Fern\u00e1ndez-Mart\u00edn JL, Rodr\u00edguez-Puyol D, \u0438 \u0434\u0440. Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study. Nephrol Dial Transplant. \u0438\u044e\u043d\u044c 2011 \u0433.;26(6):1938\u201347.","DOI":"10.1093\/ndt\/gfq304"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Mart\u00edn JL, Carrero JJ, Benedik M, Bos WJ, Covic A, Ferreira A, \u0438 \u0434\u0440. COSMOS: the dialysis scenario of CKD-MBD in Europe. Nephrol Dial Transplant. \u0438\u044e\u043b\u044c 2013 \u0433.;28(7):1922\u201335.","DOI":"10.1093\/ndt\/gfs418"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Abrita RR, Pereira B dos S, Fernandes N da S, Abrita R, Huaira RMNH, Bastos MG, \u0438 \u0434\u0440. Evaluation of prevalence, biochemical profile, and drugs associated with chronic kidney disease-mineral and bone disorder in 11 dialysis centers. J Bras Nefrol. 2018 \u0433.;40(1):26\u201334.","DOI":"10.1590\/2175-8239-jbn-3527"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Torregrosa JV, Ferreira AC, Cucchiari D, Ferreira A. Bone Mineral Disease After Kidney Transplantation. Calcif Tissue Int. \u0430\u043f\u0440\u0435\u043b\u044c 2021 \u0433.;108(4):551\u201360.","DOI":"10.1007\/s00223-021-00837-0"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Torres A, Lorenzo V, Salido E. Calcium metabolism and skeletal problems after transplantation. J Am Soc Nephrol. \u0444\u0435\u0432\u0440\u0430\u043b\u044c 2002 \u0433.;13(2):551\u20138.","DOI":"10.1681\/ASN.V132551"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Torres A, Torregrosa V, Marcen R, Campistol JM, Arias M, Hern\u00e1ndez D, \u0438 \u0434\u0440. Mineral metabolism disorders, vertebral fractures and aortic calcifications in stable kidney transplant recipients: The role of gender (EMITRAL study). Nefrologia. 2016 \u0433.;36(3):255\u201367.","DOI":"10.1016\/j.nefroe.2016.05.002"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Al Humoud H, Al-Hilali N, Ahmad A a. MH, Ninan VT, Nampoory MRN, Rizk AM, \u0438 \u0434\u0440. Vascular calcification in dialysis patients. Transplant Proc. \u0434\u0435\u043a\u0430\u0431\u0440\u044c 2005 \u0433.;37(10):4183\u20136.","DOI":"10.1016\/j.transproceed.2005.11.041"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Chen NC, Hsu CY, Chen CL. The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients. Biomed Res Int. 2017 \u0433.;2017:9035193.","DOI":"10.1155\/2017\/9035193"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Salari P, Larijani B, Abdollahi M. Association of hyperhomocysteinemia with osteoporosis: a systematic review. Clinical Practice. 2008 \u0433.;5(2):215.","DOI":"10.2217\/14750708.5.2.215"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Sharif PS, Abdollahi M. The role of platelets in bone remodeling. Inflamm Allergy Drug Targets. \u0434\u0435\u043a\u0430\u0431\u0440\u044c 2010 \u0433.;9(5):393\u20139.","DOI":"10.2174\/187152810793938044"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Salari P, Abdollahi M. Controversial effects of non-steroidal anti-inflammatory drugs on bone: a review. Inflamm Allergy Drug Targets. \u0438\u044e\u043b\u044c 2009 \u0433.;8(3):169\u201375.","DOI":"10.2174\/187152809788681065"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Salari Sharif P, Asalforoush M, Ameri F, Larijani B, Abdollahi M. The effect of n-3 fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: a randomized clinical trial. Age (Dordr). \u0438\u044e\u043d\u044c 2010 \u0433.;32(2):179\u201386.","DOI":"10.1007\/s11357-009-9122-3"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Salari Sharif P, Abdollahi M. A Systematic Review on the Relationship between \u03b2-blockers and Bone Health. International Journal of Pharmacology. 14 \u0438\u044e\u043b\u044c 2010 \u0433.;6(5):577\u201383.","DOI":"10.3923\/ijp.2010.577.583"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Abdollahi M, Larijani B, Rahimi R, Salari P. Role of oxidative stress in osteoporosis. Therapy. \u0441\u0435\u043d\u0442\u044f\u0431\u0440\u044c 2005 \u0433.;2(5):787\u201396.","DOI":"10.2217\/14750708.2.5.787"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"van Wijngaarden JP, Doets EL, Szczeci\u0144ska A, Souverein OW, Duffy ME, Dullemeijer C, \u0438 \u0434\u0440. Vitamin B12, folate, homocysteine, and bone health in adults and elderly people: a systematic review with meta-analyses. J Nutr Metab. 2013 \u0433.;2013:486186.","DOI":"10.1155\/2013\/486186"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Yang J, Hu X, Zhang Q, Cao H, Wang J, Liu B. Homocysteine level and risk of fracture: A meta-analysis and systematic review. Bone. \u0441\u0435\u043d\u0442\u044f\u0431\u0440\u044c 2012 \u0433.;51(3):376\u201382.","DOI":"10.1016\/j.bone.2012.05.024"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Brattstr\u00f6m L. Vitamins as homocysteine-lowering agents. J Nutr. \u0430\u043f\u0440\u0435\u043b\u044c 1996 \u0433.;126(4 Suppl):1276S-80S.","DOI":"10.1093\/jn\/126.suppl_4.1276S"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Holstein JH, Herrmann M, Splett C, Herrmann W, Garcia P, Histing T, \u0438 \u0434\u0440. Low serum folate and vitamin B-6 are associated with an altered cancellous bone structure in humans. Am J Clin Nutr. \u043d\u043e\u044f\u0431\u0440\u044c 2009 \u0433.;90(5):1440\u20135.","DOI":"10.3945\/ajcn.2009.28116"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Badedi M, Darraj H, Hummadi A, Solan Y, Zakri I, Khawaji A, \u0438 \u0434\u0440. Vitamin B12 Deficiency and Foot Ulcers in Type 2 Diabetes Mellitus: A Case-Control Study. Diabetes Metab Syndr Obes. 2019 \u0433.;12:2589\u201396.","DOI":"10.2147\/DMSO.S233683"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Didangelos T, Karlafti E, Kotzakioulafi E, Margariti E, Giannoulaki P, Batanis G, \u0438 \u0434\u0440. Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 27 \u044f\u043d\u0432\u0430\u0440\u044c 2021 \u0433.;13(2):395.","DOI":"10.3390\/nu13020395"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Chantelau EA, Gr\u00fctzner G. Is the Eichenholtz classification still valid for the diabetic Charcot foot? Swiss Med Wkly. 2014 \u0433.;144:w13948.","DOI":"10.4414\/smw.2014.13948"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Holmes C, Schmidt B, Munson M, Wrobel JS. Charcot stage 0: A review and consideratons for making the correct diagnosis early. Clin Diabetes Endocrinol. 2015 \u0433.;1:18.","DOI":"10.1186\/s40842-015-0018-0"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Bariteau JT, Tenenbaum S, Rabinovich A, Brodsky JW. Charcot arthropathy of the foot and ankle in patients with idiopathic neuropathy. Foot Ankle Int. \u043e\u043a\u0442\u044f\u0431\u0440\u044c 2014 \u0433.;35(10):996\u20131001.","DOI":"10.1177\/1071100714543649"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Ergen FB, Sanverdi SE, Oznur A. Charcot foot in diabetes and an update on imaging. Diabet Foot Ankle. 2013 \u0433.;4.","DOI":"10.3402\/dfa.v4i0.21884"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Richard JL, Almasri M, Schuldiner S. Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature. Diabetologia. \u043c\u0430\u0439 2012 \u0433.;55(5):1258\u201364.","DOI":"10.1007\/s00125-012-2507-3"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Bem R, Jirkovsk\u00e1 A, Fejfarov\u00e1 V, Skibov\u00e1 J, Jude EB. Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomized controlled trial. Diabetes Care. \u0438\u044e\u043d\u044c 2006 \u0433.;29(6):1392\u20134.","DOI":"10.2337\/dc06-0376"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Busch-Westbroek TE, Delpeut K, Balm R, Bus SA, Schepers T, Peters EJ, \u0438 \u0434\u0440. Effect of Single Dose of RANKL Antibody Treatment on Acute Charcot Neuro-osteoarthropathy of the Foot. Diabetes Care. \u043c\u0430\u0440\u0442 2018 \u0433.;41(3):e21\u20132.","DOI":"10.2337\/dc17-1517"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Rastogi A, Hajela A, Prakash M, Khandelwal N, Kumar R, Bhattacharya A, \u0438 \u0434\u0440. Teriparatide (recombinant human parathyroid hormone [1-34]) increases foot bone remodeling in diabetic chronic Charcot neuroarthropathy: a randomized double-blind placebo-controlled study. J Diabetes. \u0441\u0435\u043d\u0442\u044f\u0431\u0440\u044c 2019 \u0433.;11(9):703\u201310.","DOI":"10.1111\/1753-0407.12902"}],"container-title":["Problems of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/viewFile\/13362\/10709","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T16:43:28Z","timestamp":1726591408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/view\/13362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,15]]},"references-count":74,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,9,16]]}},"URL":"https:\/\/doi.org\/10.14341\/probl13362","relation":{},"ISSN":["2308-1430","0375-9660"],"issn-type":[{"type":"electronic","value":"2308-1430"},{"type":"print","value":"0375-9660"}],"subject":[],"published":{"date-parts":[[2024,9,15]]}}}